Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MRKRMarker Therapeutics, Inc.

Nasdaq · CIK 0001094038
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts489

Identity from submissions API

NameMarker Therapeutics, Inc.
CIK0001094038
TickersMRKR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN880277072
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(713) 400-6400
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • TAPIMMUNE INC. (2017-07-11T00:00:00.000Z → 2018-10-17T00:00:00.000Z)
  • TAPIMMUNE INC (2007-07-03T00:00:00.000Z → 2017-06-29T00:00:00.000Z)
  • GENEMAX CORP (2002-07-18T00:00:00.000Z → 2007-06-28T00:00:00.000Z)
  • EDUVERSE COM (1999-09-29T00:00:00.000Z → 2002-06-17T00:00:00.000Z)
Business address
2450 HOLCOMBE BLVD
TMC PARTNERS OFFICE 1.311
HOUSTON
TX
77021
TX
Mailing address
2450 HOLCOMBE BLVD
TMC PARTNERS OFFICE 1.311
HOUSTON
TX
77021
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

906 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K FORM 8-K 8.01,9.01 0001104659-26-129934 001-37939 261572282 34 238813 1 1
2026-11-16 10-Q 10-Q 0001104659-26-128441 001-37939 261562102 34 6003257 1 1
2026-10-19 8-K FORM 8-K 8.01,9.01 0001104659-26-116720 001-37939 261467496 34 219851 1 1
2026-08-14 10-Q 10-Q 0001104659-26-097262 001-37939 261282803 34 5538893 1 1
2026-05-15 10-Q 10-Q 0001104659-26-062763 001-37939 26989453 34 4635442 1 1
2026-05-04 8-K FORM 8-K 5.03,5.07,9.01 0001104659-26-054940 001-37939 26938204 34 224244 1 1
2026-03-20 DEFA14A DEFA14A 0001104659-26-032708 001-37939 26778319 34 477669
2026-03-20 ARS ARS 0001104659-26-032704 001-37939 26778300 34 16248922
2026-03-20 DEF 14A FORM DEF 14A 0001104659-26-032694 001-37939 26778271 34 2977402 1 1
2026-03-19 8-K FORM 8-K 2.02,9.01 0001104659-26-031309 001-37939 26770711 34 315759 1 1
2026-03-18 10-K 10-K 0001104659-26-031274 001-37939 26770583 34 8635566 1 1
2026-03-10 PRE 14A FORM PRE 14A 0001104659-26-025917 001-37939 26740229 34 2689462 1 1
2026-02-09 8-K FORM 8-K 5.08,9.01 0001104659-26-012063 001-37939 26611482 34 190768 1 1
2025-11-19 4 PRIMARY DOCUMENT 0001768011-25-000003 8354
2025-11-19 4 PRIMARY DOCUMENT 0001270905-25-000003 8399
2025-11-19 4 OWNERSHIP DOCUMENT 0001104659-25-114081 8540
2025-11-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000858 005-58217 251491329 34 79922
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005191 005-58217 251489024 34 11650
2025-11-14 8-K FORM 8-K 2.02,9.01 0001104659-25-111940 001-37939 251481172 34 336395 1 1
2025-11-13 10-Q 10-Q 0001104659-25-111502 001-37939 251479927 34 5385638 1 1
2025-11-05 8-K FORM 8-K 5.02,8.01,9.01 0001104659-25-106669 001-37939 251451796 34 222534 1 1
2025-11-04 4 PRIMARY DOCUMENT 0001884123-25-000010 5883
2025-11-04 4 PRIMARY DOCUMENT 0001755495-25-000003 6081
2025-11-04 3 PRIMARY DOCUMENT 0001884123-25-000009 7250
2025-10-06 8-K FORM 8-K 8.01,9.01 0001104659-25-096935 001-37939 251375618 34 237041 1 1
2025-08-26 8-K FORM 8-K 7.01,9.01 0001104659-25-082783 001-37939 251252609 34 10580780 1 1
2025-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-080957 005-58217 251237518 34 38091
2025-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-080213 005-58217 251231174 34 31441
2025-08-18 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000647 005-58217 251228982 34 79398
2025-08-14 10-Q 10-Q 0001410578-25-001826 001-37939 251221010 34 5395815 1 1
2025-08-12 8-K FORM 8-K 4.01,9.01 0001104659-25-076834 001-37939 251206712 34 245809 1 1
2025-08-05 424B7 424B7 0001104659-25-074154 333-228059 251184679 33 22137
2025-06-17 8-K FORM 8-K 1.01,8.01,9.01 0001104659-25-060092 001-37939 251051854 34 217608 1 1
2025-06-09 8-K FORM 8-K 5.07,9.01 0001104659-25-057836 001-37939 251034237 34 203723 1 1
2025-05-20 8-K FORM 8-K 8.01,9.01 0001104659-25-050771 001-37939 25966317 34 238485 1 1
2025-05-15 10-Q 10-Q 0001410578-25-001342 001-37939 25955121 34 4732905 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-019283 005-58217 25953186 34 7982
2025-04-24 ARS ARS 0001104659-25-038714 001-37939 25868270 34 16720183
2025-04-24 DEFA14A DEFA14A 0001104659-25-038711 001-37939 25868252 34 409294
2025-04-24 DEF 14A FORM DEF 14A 0001104659-25-038633 001-37939 25868234 34 2941779 1 1
2025-03-31 8-K FORM 8-K 2.02,9.01 0001104659-25-029666 001-37939 25789132 34 315831 1 1
2025-03-31 10-K 10-K 0001410578-25-000549 001-37939 25789030 34 8949836 1 1
2025-03-27 8-K FORM 8-K 5.07 0001104659-25-028821 001-37939 25780275 34 202257 1 1
2025-03-04 8-K/A FORM 8-K/A 5.02,8.01 0001104659-25-020405 001-37939 25706117 34 203099 1 1
2025-02-19 8-K FORM 8-K 5.02,8.01 0001104659-25-015224 001-37939 25641462 34 200967 1 1
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014321 6100
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014318 6140
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014317 6204
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014315 6173
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-004890 005-58217 25630757 34 7124
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001176 005-58217 25629450 34 11618
2025-02-04 DEFA14A DEFA14A 0001104659-25-009099 001-37939 25588136 34 392238
2025-02-04 DEF 14A DEF 14A 0001104659-25-009098 001-37939 25588108 34 990683
2025-01-30 8-K FORM 8-K 5.02 0001104659-25-007574 001-37939 25573669 34 197974 1 1
2025-01-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000144 333-284233 25540225 33 2060
2025-01-17 424B3 424B3 0001104659-25-004477 333-284233 25538801 33 457791
2025-01-15 CORRESP filename1.htm 0001104659-25-003764 15637
2025-01-15 UPLOAD filename1.pdf 0000000000-25-000426 333-284233 40405
2025-01-13 PRE 14A PRE 14A 0001104659-25-003033 001-37939 25526394 34 991038
2025-01-10 S-3 S-3 0001104659-25-002600 333-284233 25523875 33 633139
2024-12-30 D xslFormDX01/primary_doc.xml 06b 0001104659-24-132525 021-533696 241590356 33 11543
2024-12-26 4 OWNERSHIP DOCUMENT 0001104659-24-131704 7225
2024-12-23 4 4 0000950170-24-139630 45677
2024-12-23 8-K FORM 8-K 1.01,3.02,9.01 0001104659-24-131322 001-37939 241574044 34 1280294 1 1
2024-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-24-000928 005-58217 241574041 34 81842 1 1
2024-12-19 8-K FORM 8-K 1.01,8.01,9.01 0001104659-24-130002 001-37939 241561048 34 661103 1 1
2024-12-17 8-K FORM 8-K 8.01,9.01 0001104659-24-129181 001-37939 241553644 34 231223 1 1
2024-12-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-12-06 16:00:00 9999999995-24-003698 333-283512 241533668 33 2061
2024-12-06 424B3 424B3 0001104659-24-126320 333-283512 241532691 33 726521
2024-12-04 CORRESP filename1.htm 0001104659-24-125470 17440
2024-12-04 UPLOAD filename1.pdf 0000000000-24-013351 333-283512 40372
2024-11-27 S-3 S-3 0001104659-24-123679 333-283512 241511585 33 1963459
2024-11-14 8-K FORM 8-K 2.02,9.01 0001104659-24-119077 001-37939 241463640 34 340083 1 1
2024-11-14 10-Q 10-Q 0001410578-24-001978 001-37939 241461916 34 5599201 1 1
2024-08-14 8-K FORM 8-K 2.02,9.01 0001104659-24-089704 001-37939 241209037 34 335214 1 1
2024-08-14 10-Q 10-Q 0001410578-24-001454 001-37939 241208868 34 5559843 1 1
2024-08-12 8-K FORM 8-K 8.01,9.01 0001104659-24-088054 001-37939 241194723 34 272684 1 1
2024-06-12 8-K FORM 8-K 5.07,8.01 0001104659-24-070830 001-37939 241038416 34 209887 1 1
2024-05-17 SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A 0001072613-24-000515 005-58217 24961869 34 404652
2024-05-15 8-K FORM 8-K 2.02,9.01 0001104659-24-062001 001-37939 24951973 34 378974 1 1
2024-05-15 10-Q 10-Q 0001410578-24-000865 001-37939 24950225 34 4696063 1 1
2024-04-26 ARS ARS 0001104659-24-052923 001-37939 24883661 34 2928262
2024-04-26 DEF 14A DEF 14A 0001104659-24-052914 001-37939 24883524 34 1687019
2024-04-08 8-K FORM 8-K 8.01,9.01 0001104659-24-044496 001-37939 24828160 34 228572 1 1
2024-03-26 8-K FORM 8-K 2.02,9.01 0001104659-24-038533 001-37939 24780429 34 326002 1 1
2024-03-26 10-K 10-K 0001410578-24-000297 001-37939 24780333 34 9852287 1 1
2024-03-01 8-K FORM 8-K 1.02 0001104659-24-029638 001-37939 24707028 34 198312 1 1
2024-02-26 8-K FORM 8-K 1.01,9.01 0001104659-24-027293 001-37939 24673585 34 196223 1 1
2024-01-08 8-K FORM 8-K 7.01,9.01 0001104659-24-002086 001-37939 24518492 34 4529132 1 1
2023-12-11 8-K FORM 8-K 8.01,9.01 0001104659-23-124869 001-37939 231476918 34 227278 1 1
2023-11-20 8-K FORM 8-K 5.02 0001104659-23-119946 001-37939 231423265 34 193529 1 1
2023-11-09 8-K FORM 8-K 2.02,9.01 0001104659-23-116364 001-37939 231393611 34 318473 1 1
2023-11-09 10-Q 10-Q 0001410578-23-002307 001-37939 231393127 34 6212659 1 1
2023-09-11 8-K FORM 8-K 8.01,9.01 0001104659-23-099485 001-37939 231246679 34 225314 1 1
2023-08-14 8-K FORM 8-K 2.02,9.01 0001104659-23-091425 001-37939 231171228 34 337703 1 1
2023-08-14 10-Q 10-Q 0001410578-23-001875 001-37939 231169678 34 6118667 1 1
2023-08-07 8-K FORM 8-K 7.01,9.01 0001104659-23-088072 001-37939 231145582 34 232478 1 1
2023-07-10 8-K FORM 8-K 7.01,9.01 0001104659-23-079310 001-37939 231078222 34 223845 1 1
2023-07-05 3 FORM 3 SUBMISSION 0001209191-23-041053 7250
2023-07-03 8-K FORM 8-K 5.02 0001104659-23-077598 001-37939 231065321 34 196658 1 1
2023-06-30 8-K FORM 8-K 2.01,9.01 0001104659-23-077074 001-37939 231061683 34 348789 1 1
2023-06-26 8-K FORM 8-K 7.01,9.01 0001104659-23-074513 001-37939 231039418 34 279395 1 1
2023-06-12 8-K FORM 8-K 7.01,9.01 0001104659-23-070151 001-37939 231007080 34 230156 1 1
2023-06-09 8-K FORM 8-K 5.07 0001104659-23-069896 001-37939 231005238 34 211369 1 1
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035617 12908
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035616 5571
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035615 5534
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035614 5537
2023-05-31 8-K FORM 8-K 7.01,9.01 0001104659-23-066311 001-37939 23978892 34 229674 1 1
2023-05-15 10-Q 10-Q 0001410578-23-001217 001-37939 23922221 34 5350572 1 1
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028846 5700
2023-05-08 8-K FORM 8-K 7.01,9.01 0001104659-23-056863 001-37939 23895882 34 222214 1 1
2023-05-01 8-K FORM 8-K 1.01,5.02,7.01,9.01 0001104659-23-053509 001-37939 23870036 34 245114 1 1
2023-04-28 ARS ARS 0001104659-23-052941 001-37939 23866105 34 3735086
2023-04-28 DEF 14A DEF 14A 0001104659-23-052923 001-37939 23865950 34 3123547
2023-03-22 424B5 424B5 0001104659-23-035382 333-258687 23751475 33 21573
2023-03-22 8-K FORM 8-K 2.02,9.01 0001104659-23-035380 001-37939 23751471 34 318910 1 1
2023-03-22 10-K 10-K 0001410578-23-000324 001-37939 23751448 34 9157909 1 1
2023-03-16 8-K FORM 8-K 5.02 0001104659-23-033300 001-37939 23738754 34 192616 1 1
2023-03-03 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-23-017251 005-58217 23704571 34 112842
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014168 5692
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014165 5674
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014161 5720
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014158 5675
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014157 5707
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014155 5705
2023-01-26 8-K FORM 8-K 5.03,9.01 0001104659-23-007019 001-37939 23557914 34 216858 1 1
2023-01-03 424B3 424B3 0001104659-23-000118 333-268979 23500454 33 411859
2022-12-30 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-12-30 16:00:00 9999999995-23-000015 333-268979 23500010 33 1951
2022-12-29 CORRESP filename1.htm 0001104659-22-130877 7896
2022-12-29 UPLOAD filename1.pdf 0000000000-22-013978 40289
2022-12-23 S-1 S-1 0001104659-22-129742 333-268979 221483482 33 804220
2022-12-13 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001104659-22-126446 001-37939 221458549 34 677085 1 1
2022-11-22 8-K FORM 8-K 7.01,9.01 0001104659-22-120986 001-37939 221407464 34 225858 1 1
2022-11-10 8-K FORM 8-K 2.02,9.01 0001104659-22-117148 001-37939 221377426 34 305766 1 1
2022-11-10 10-Q 10-Q 0001410578-22-003131 001-37939 221377001 34 5652470 1 1
2022-10-20 8-K FORM 8-K 1.02 0001104659-22-110309 001-37939 221321477 34 195412 1 1
2022-09-27 8-K FORM 8-K 5.02 0001104659-22-103164 001-37939 221267440 34 193362 1 1
2022-09-13 8-K FORM 8-K 7.01,9.01 0001104659-22-099500 001-37939 221239837 34 238256 1 1
2022-08-19 8-K FORM 8-K 3.01 0001104659-22-092803 001-37939 221178983 34 196153 1 1
2022-08-11 S-8 FORM S-8 0001104659-22-089426 333-266797 221156883 33 300295
2022-08-11 8-K FORM 8-K 2.02,9.01 0001104659-22-089401 001-37939 221156523 34 330872 1 1
2022-08-11 10-Q 10-Q 0001410578-22-002292 001-37939 221156494 34 5740368 1 1
2022-08-04 8-K FORM 8-K 7.01,9.01 0001104659-22-086190 001-37939 221137447 34 259426 1 1
2022-05-27 8-K 8-K 5.03,5.07,9.01 0001193125-22-162322 001-37939 22977368 34 193184 1 1
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032180 5555
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032175 5589
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032172 5592
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032169 5558
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032166 5652
2022-05-13 8-K FORM 8-K 2.02,9.01 0001104659-22-059849 001-37939 22920217 34 308237 1 1
2022-05-13 10-Q 10-Q 0001410578-22-001389 001-37939 22919645 34 4766515 1 1
2022-04-26 8-K FORM 8-K 1.01,7.01,9.01 0001104659-22-049970 001-37939 22851754 34 260493 1 1
2022-04-15 DEF 14A DEF 14A 0001104659-22-046490 001-37939 22830310 34 4379895
2022-04-06 PRE 14A PRE 14A 0001104659-22-043219 001-37939 22810681 34 4379937
2022-04-06 8-K FORM 8-K 5.02 0001104659-22-043215 001-37939 22810662 34 197050 1 1
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021396 6702
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021395 6675
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021394 6672
2022-03-18 424B5 424B5 0001104659-22-035691 333-258687 22753515 33 51001
2022-03-18 8-K FORM 8-K 2.02,9.01 0001104659-22-035160 001-37939 22750250 34 352701 1 1
2022-03-17 10-K 10-K 0001410578-22-000418 001-37939 22749956 34 8057525 1 1
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011791 5758
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011787 5729
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011786 5758
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011782 5774
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011779 5728
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011776 5728
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011769 5743
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011761 5764
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011745 5755
2022-02-18 8-K FORM 8-K 3.01 0001104659-22-025147 001-37939 22652657 34 197425 1 1
2022-02-16 8-K FORM 8-K 8.01,9.01 0001104659-22-024289 001-37939 22644008 34 244129 1 1
2022-01-20 8-K FORM 8-K 7.01,9.01 0001104659-22-005535 001-37939 22539865 34 220396 1 1
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068837 5677
2021-12-09 3 FORM 3 SUBMISSION 0001209191-21-068833 8021
2021-12-09 8-K FORM 8-K 5.02,7.01,9.01 0001104659-21-147884 001-37939 211480312 34 229148 1 1
2021-11-15 8-K FORM 8-K 5.02 0001104659-21-138506 001-37939 211406241 34 197379 1 1
2021-11-10 8-K FORM 8-K 2.02,9.01 0001104659-21-136967 001-37939 211397107 34 310639 1 1
2021-11-10 10-Q 10-Q 0001410578-21-000089 001-37939 211396630 34 5052540 1 1
2021-08-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-19 16:00:00 9999999995-21-003254 333-258687 211191632 33 1994
2021-08-19 8-K FORM 8-K 7.01,9.01 0001104659-21-107740 001-37939 211190226 34 225218 1 1
2021-08-17 CORRESP filename1.htm 0001104659-21-107079 10764
2021-08-17 UPLOAD filename1.pdf 0000000000-21-010111 40464
2021-08-10 S-3 S-3 0001104659-21-102945 333-258687 211160986 33 1841725
2021-08-10 8-K FORM 8-K 2.02,9.01 0001104659-21-102841 001-37939 211159941 34 322904 1 1
2021-08-10 10-Q 10-Q 0001104659-21-102826 001-37939 211159816 34 4716309 1 1
2021-07-28 8-K FORM 8-K 7.01,9.01 0001104659-21-096990 001-37939 211123024 34 221095 1 1
2021-07-06 8-K FORM 8-K 7.01,9.01 0001104659-21-089167 001-37939 211072476 34 231160 1 1
2021-06-11 8-K FORM 8-K 5.07 0001104659-21-079831 001-37939 211009985 34 210901 1 1
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039635 5117
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039634 5134
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039632 6793
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039631 5197
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039629 5102
2021-05-20 4 FORM 4 SUBMISSION 0001209191-21-034427 4730
2021-05-12 8-K 8-K 2.02,9.01 0001104659-21-065132 001-37939 21915330 34 337354 1 1
2021-05-12 10-Q FORM 10-Q 0001104659-21-065131 001-37939 21915323 34 3966320 1 1
2021-05-05 DEFR14A DEFR14A 0001104659-21-061740 001-37939 21893731 34 64230
2021-04-23 DEFA14A DEFA14A 0001104659-21-054487 001-37939 21850248 34 656888
2021-04-23 DEF 14A DEF 14A 0001104659-21-054483 001-37939 21850232 34 3299280
2021-03-26 SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. (MARKER THERAPEUTICS) - SCHEDULE 13DA1 0001072613-21-000318 005-58217 21775460 34 438152
2021-03-24 SC 13D/A SC 13D/A 0001104659-21-040445 005-58217 21766135 34 47064
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021818 5494
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021817 5456
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021816 5364
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021815 5469
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021814 5458
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021813 5496
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021812 5448
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021811 5460
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021810 5362
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021809 8788
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021775 4715
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021773 4820
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021771 4857
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021769 6411
2021-03-16 8-K FORM 8-K 1.01,7.01,8.01,9.01 0001104659-21-037220 001-37939 21747020 34 10873691 1 1
2021-03-15 SC 13D/A SCHEDULE 13D/A 0001408408-21-000011 005-58217 21742070 34 60204
2021-03-15 424B5 424B5 0001104659-21-036276 333-232122 21741866 33 509683
2021-03-11 424B5 424B5 0001104659-21-035002 333-232122 21733309 33 507877
2021-03-09 10-K 10-K 0001104659-21-033855 001-37939 21726581 34 8051759 1 1
2021-03-09 8-K FORM 8-K 2.02,9.01 0001104659-21-033842 001-37939 21726392 34 312062 1 1
2021-03-03 8-K FORM 8-K 7.01,9.01 0001104659-21-031116 001-37939 21707239 34 234688 1 1
2021-02-24 4 FORM 4 0001104659-21-027293 3591
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010312 5720
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010306 5758
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010302 5774
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010297 5728
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010285 5728
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010278 5743
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010267 5758
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010262 5764
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010256 5755
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010250 5237
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010241 5252
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010231 5269
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010226 6710
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010224 5332
2021-01-13 8-K FORM 8-K 7.01,9.01 0001104659-21-003664 001-37939 21525079 34 219926 1 1
2021-01-05 8-K FORM 8-K 7.01,9.01 0001104659-21-000891 001-37939 21505353 34 503960 1 1
2020-11-13 4 xslF345X03/ownership.xml 0001408408-20-000054 9072
2020-11-13 SC 13D/A SCHEDULE 13D/A 0001408408-20-000052 005-58217 201311648 34 53582
2020-11-09 8-K FORM 8-K 2.02,9.01 0001104659-20-123073 001-37939 201297931 34 316946 1 1
2020-11-09 10-Q FORM 10-Q 0001104659-20-123055 001-37939 201297744 34 6656746 1 1
2020-08-10 8-K FORM 8-K 2.02,9.01 0001104659-20-092766 001-37939 201089792 34 594672 1 1
2020-08-10 10-Q 10-Q 0001104659-20-092706 001-37939 201089266 34 5845868 1 1
2020-06-30 8-K 8-K 7.01,9.01 0001104659-20-078459 001-37939 201000628 34 36871
2020-06-23 8-K FORM 8-K 7.01,9.01 0001104659-20-075877 001-37939 20980426 34 34100
2020-06-19 4 xslF345X03/ownership.xml 0001408408-20-000029 9535
2020-06-18 SC 13D/A SCHEDULE 13D/A 0001408408-20-000027 005-58217 20973200 34 65623
2020-06-12 S-8 S-8 0001104659-20-072918 333-239136 20960386 33 365286
2020-06-01 8-K FORM 8-K 7.01,9.01 0001104659-20-068051 001-37939 20931323 34 4318652
2020-05-29 8-K 8-K 8.01,9.01 0001104659-20-067357 001-37939 20924091 34 56903
2020-05-21 8-K FORM 8-K 5.07 0001104659-20-064746 001-37939 20901896 34 33423
2020-05-11 8-K FORM 8-K 2.02,9.01 0001104659-20-059559 001-37939 20865026 34 391997
2020-05-11 10-Q FORM 10-Q 0001104659-20-059515 001-37939 20864711 34 3727330 1
2020-04-29 8-K 8-K 8.01,9.01 0001104659-20-053395 001-37939 20830559 34 37547
2020-04-17 DEF 14A DEF 14A 0001104659-20-048175 001-37939 20799660 34 2876459
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018556 8266
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018548 8248
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018543 8278
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018539 8302
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018535 8251
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018534 8233
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018531 8272
2020-03-12 8-K FORM 8-K 2.02,9.01 0001104659-20-032531 001-37939 20709326 34 108770
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018528 8284
2020-03-12 4 FORM 4 SUBMISSION 0001209191-20-018524 8275
2020-03-12 3 FORM 3 SUBMISSION 0001209191-20-018519 8613
2020-03-12 3 FORM 3 SUBMISSION 0001209191-20-018515 9710
2020-03-12 10-K FORM 10-K 0001104659-20-032463 001-37939 20708735 34 7430765 1
2020-03-03 424B5 424B5 0001104659-20-028589 333-232122 20683043 33 680753
2020-03-02 8-K FORM 8-K 1.01,7.01,9.01 0001104659-20-027550 001-37939 20674408 34 398126
2020-02-20 4 xslF345X03/ownership.xml 0001408408-20-000011 10825
2020-02-20 SC 13D/A SCHEDULE 13 D/A 0001408408-20-000008 005-58217 20635469 34 73904
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038347 005-58217 20620598 34 63822
2020-02-11 8-K FORM 8-K 8.01,9.01 0001104659-20-015276 001-37939 20593845 34 50804
2019-11-12 8-K FORM 8-K 2.02,9.01 0001104659-19-062634 001-37939 191209642 34 404572
2019-11-12 10-Q FORM 10-Q 0001104659-19-062594 001-37939 191209201 34 4059872 1
2019-09-24 8-K 8-K 7.01,9.01 0001144204-19-045766 001-37939 191110865 34 2540926
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046630 5739
2019-08-19 3 FORM 3 SUBMISSION 0001209191-19-046625 7370
2019-08-15 4 FORM 4 SUBMISSION 0001209191-19-046149 5373
2019-08-15 8-K FORM 8-K 7.01,9.01 0001144204-19-040272 001-37939 191030457 34 322491
2019-08-09 10-Q FORM 10-Q 0001144204-19-038714 001-37939 191011411 34 3889620 1
2019-08-09 8-K FORM 8-K 2.02,9.01 0001144204-19-038680 001-37939 191011194 34 127081
2019-08-08 4 FORM 4 SUBMISSION 0001209191-19-045152 5634
2019-08-08 3 FORM 3 SUBMISSION 0001209191-19-045148 9801
2019-08-06 8-K FORM 8-K 5.02,7.01,9.01 0001144204-19-037903 001-37939 191002800 34 40126
2019-07-22 8-K 8-K 7.01,8.01,9.01 0001144204-19-035266 001-37939 19964547 34 3443503
2019-07-19 8-K FORM 8-K 7.01 0001144204-19-035118 001-37939 19962404 34 18495
2019-06-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-06-25 16:00:00 9999999995-19-001442 333-232122 19919880 33 1993
2019-06-21 CORRESP filename1.htm 0001144204-19-031879 7708
2019-06-20 UPLOAD filename1.pdf 0000000000-19-010106 40151
2019-06-20 8-K FORM 8-K 7.01,9.01 0001144204-19-031591 001-37939 19907454 34 324931
2019-06-14 S-3 FORM S-3 0001144204-19-030986 333-232122 19898902 33 1221881
2019-05-15 3 FORM 3 0001144204-19-026544 15578
2019-05-13 4 OWNERSHIP DOCUMENT 0001144204-19-025608 5253
2019-05-13 4 OWNERSHIP DOCUMENT 0001144204-19-025607 5158
2019-05-13 4 OWNERSHIP DOCUMENT 0001144204-19-025605 5191
2019-05-13 4 OWNERSHIP DOCUMENT 0001144204-19-025602 5173
2019-05-10 8-K FORM 8-K 5.07 0001144204-19-025325 001-37939 19815870 34 27791
2019-05-10 10-Q 10-Q 0001144204-19-025316 001-37939 19815836 34 4634808 1
2019-05-09 8-K FORM 8-K 2.02,9.01 0001144204-19-024949 001-37939 19811643 34 128257
2019-04-17 8-K FORM 8-K 8.01 0001144204-19-019976 001-37939 19752189 34 16967
2019-04-01 CT ORDER filename1.pdf 20190401,20190401 9999999997-19-002227 001-37939 19719917 34 93694
2019-03-28 DEFA14A DEFA14A 0001144204-19-016699 001-37939 19712915 34 34520
2019-03-28 DEF 14A DEF 14A 0001144204-19-016692 001-37939 19712891 34 422547
2019-03-28 8-K FORM 8-K 8.01,9.01 0001144204-19-016685 001-37939 19712838 34 68867
2019-03-15 10-K FORM 10-K 0001144204-19-014350 001-37939 19685760 34 11017448 1
2019-02-25 8-K 8-K 8.01,9.01 0001144204-19-009717 001-37939 19628171 34 12726317
2019-02-15 8-K FORM 8-K 5.08,8.01,9.01 0001144204-19-008704 001-37939 19612240 34 325169
2019-02-14 SC 13G SC 13G 0001193125-19-040985 005-58217 19607277 34 65131
2019-02-14 SC 13D SC 13D 0001144204-19-007762 005-58217 19602812 34 47520
2019-02-14 SC 13D SC 13D 0001144204-19-007755 005-58217 19602781 34 48657
2019-02-14 SC 13D SC 13D 0001144204-19-007747 005-58217 19602741 34 49892
2019-02-04 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-19-001621 005-58217 19561837 34 42859
2019-01-29 424B7 424B7 0001144204-19-003213 333-228059 19546737 33 54505
2019-01-15 8-K 8-K 8.01,9.01 0001144204-19-001768 001-37939 19527661 34 322922
2019-01-04 8-K FORM 8-K 8.01,9.01 0001144204-19-000592 001-37939 19509046 34 70528
2018-12-28 3 OWNERSHIP DOCUMENT 0001144204-18-066584 17052
2018-12-28 3 FORM 3 0001144204-18-066575 17107
2018-12-28 3 OWNERSHIP DOCUMENT 0001144204-18-066573 12877
2018-12-04 8-K FORM 8-K 8.01,9.01 0001144204-18-062948 001-37939 181215167 34 4733056
2018-12-03 8-K 8-K 5.02,9.01 0001144204-18-062867 001-37939 181214142 34 172119
2018-11-29 4 OWNERSHIP DOCUMENT 0001144204-18-062322 6070
2018-11-29 3 OWNERSHIP DOCUMENT 0001144204-18-062320 13791
2018-11-27 8-K FORM 8-K 8.01,9.01 0001144204-18-061745 001-37939 181203543 34 319715
2018-11-27 8-K FORM 8-K 8.01,9.01 0001144204-18-061604 001-37939 181202092 34 321463
2018-11-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-11-16 16:00:00 9999999995-18-002918 333-228059 181191163 33 2000
2018-11-16 424B3 424B3 0001144204-18-060520 333-228059 181190123 33 283342
2018-11-13 CORRESP filename1.htm 0001144204-18-059361 15974
2018-11-13 10-Q 10-Q 0001144204-18-059353 001-37939 181177954 34 4198133 1
2018-11-13 UPLOAD filename1.pdf 0000000000-18-035057 46287
2018-11-08 SC 13D/A SCHEDULE 13D/A 0001408408-18-000021 005-58217 181168728 34 80358
2018-10-30 S-3 S-3 0001144204-18-056186 333-228059 181147582 33 408271
2018-10-30 S-8 S-8 0001144204-18-056172 333-228056 181147440 33 141456
2018-10-30 8-K 8-K 8.01 0001144204-18-056154 001-37939 181147166 34 945150
2018-10-29 8-K/A FORM 8-K/A 9.01 0001144204-18-055613 001-37939 181142471 34 406757
2018-10-25 SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - MARKER THERAPEUTICS, INC. 13D 0001072613-18-000512 005-58217 181139046 34 464353
2018-10-23 4 OWNERSHIP DOCUMENT 0001144204-18-054994 8645
2018-10-23 4 OWNERSHIP DOCUMENT 0001144204-18-054993 6117
2018-10-23 4 OWNERSHIP DOCUMENT 0001144204-18-054992 5947
2018-10-23 8-K FORM 8-K 1.01,5.02,8.01,9.01 0001144204-18-054989 001-37939 181134674 34 196540
2018-10-19 SC 13D SCHEDULE 13D 0001193125-18-303199 005-58217 181130999 34 154456
2018-10-19 4 OWNERSHIP DOCUMENT 0001144204-18-054586 5985
2018-10-19 4 OWNERSHIP DOCUMENT 0001144204-18-054584 5886
2018-10-19 3 OWNERSHIP DOCUMENT 0001144204-18-054565 14625
2018-10-19 3 OWNERSHIP DOCUMENT 0001144204-18-054562 15398
2018-10-19 3 OWNERSHIP DOCUMENT 0001144204-18-054557 13604
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055571 5790
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055570 5786
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055569 5752
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055568 5660
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055567 5754
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055566 5767
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055564 5754
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055563 5792
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055562 5744
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055561 5756
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055560 5658
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055559 5757
2018-10-18 3 FORM 3 SUBMISSION 0001209191-18-055558 8993
2018-10-17 8-A12B/A 8-A12B/A 0001144204-18-054210 001-37939 181126457 34 909908
2018-10-17 8-K 8-K 1.01,2.01,3.02,5.02,5.07,8.01,9.01 0001144204-18-054209 001-37939 181126453 34 707475
2018-10-17 4 OWNERSHIP DOCUMENT 0001144204-18-054109 5905
2018-10-17 4 OWNERSHIP DOCUMENT 0001144204-18-054107 5200
2018-10-17 4 OWNERSHIP DOCUMENT 0001144204-18-054105 5136
2018-10-17 4 OWNERSHIP DOCUMENT 0001144204-18-054103 5179
2018-10-17 4 OWNERSHIP DOCUMENT 0001144204-18-054101 5162
2018-10-10 4 OWNERSHIP DOCUMENT 0001144204-18-053247 9155
2018-09-25 4 OWNERSHIP DOCUMENT 0001144204-18-050737 5927
2018-09-14 DEFM14A DEFM14A 0001144204-18-049481 001-37939 181070942 34 10702752
2018-09-07 PRER14A REVISED PRELIMINARY PROXY STATEMENT 0001571049-18-000475 001-37939 181060936 34 11140473
2018-08-09 10-Q FORM 10-Q 0001144204-18-043366 001-37939 181006174 34 3361295 1
2018-08-08 8-K FORM 8-K 8.01,9.01 0001144204-18-042861 001-37939 181001960 34 51677
2018-08-08 DEFA14A FORM 8-K 0001144204-18-042863 001-37939 181001939 34 51597
2018-07-13 PREM14A PREM14A 0001144204-18-038363 001-37939 18953127 34 10299818
2018-06-21 424B7 424B7 0001144204-18-035109 333-220538 18911482 33 43920
2018-06-15 424B7 424B7 0001144204-18-034436 333-220538 18902684 33 35806
2018-06-08 8-K FORM 8-K 1.01,3.02,9.01 0001144204-18-033374 001-37939 18888205 34 490842
2018-05-24 D xslFormDX01/primary_doc.xml 06b 0001144204-18-030789 021-313217 18857852 33 10654
2018-05-18 8-K FORM 8-K 1.01,3.02,9.01 0001144204-18-029884 001-37939 18847631 34 23993
2018-05-16 4 OWNERSHIP DOCUMENT 0001408408-18-000007 8678
2018-05-16 SC 13D/A SCHEDULE 13D/A 0001408408-18-000005 005-58217 18840857 34 81103
2018-05-15 10-Q FORM 10-Q 0001144204-18-028862 001-37939 18836381 34 2444867 1
2018-05-15 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001144204-18-028370 001-37939 18832866 34 8379878
2018-05-15 DEFA14A 8-K 0001144204-18-028371 001-37939 18832854 34 8379633
2018-04-04 SC 13D sc13d07042012_04042018.htm 0000921895-18-001200 005-58217 18737589 34 179270
2018-03-23 S-8 FORM S-8 0001144204-18-016745 333-223900 18711098 33 226626
2018-03-23 10-K FORM 10-K 0001144204-18-016734 001-37939 18711028 34 6453750 1
2018-03-02 4 OWNERSHIP DOCUMENT 0001144204-18-012627 18939
2018-02-14 SC 13G/A c90525_sc13g.htm 0000930413-18-000507 005-58217 18613905 34 50152
2018-01-26 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-18-000939 005-58217 18552072 34 76496
2017-12-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-12-29 16:30:00 9999999995-18-000012 333-220538 18500018 33 1975
2017-12-29 424B3 424B3 0001144204-17-065906 333-220538 171282441 33 431024
2017-12-29 CORRESP filename1.htm 0001144204-17-065719 14598
2017-12-28 S-3/A S-3/A 0001144204-17-065626 333-220538 171278324 33 471916
2017-12-22 UPLOAD filename1.pdf 0000000000-17-044976 134642

Latest XBRL company facts

One latest value per concept from companyfacts (489 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 16.67M 2026-11-13 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
dei EntityPublicFloat Entity Public Float USD 17.31M 2025-06-30 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities (Deprecated 2009-01-31) USD 1.33M 2012-09-30 2012 Q3 10-Q 2012-11-19 0001554757-12-000408
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 693,362 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccountsPayableAndAccruedLiabilitiesFairValueDisclosure Accounts Payable and Accrued Liabilities, Fair Value Disclosure USD 967,358 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 2.42M 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 68,448 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 866,769 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 76,360 2017-03-31 2017 Q1 10-Q 2017-05-05 0001144204-17-024823
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 620,826 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 150,500 2012-05-31 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap AccretionOfDiscount Accretion of Discount (Deprecated 2016-01-31) USD 492,296 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 65,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001410578-24-000865
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4,088 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 2.40M 2021-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 140,015 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 6.09M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap AccumulatedOtherComprehensiveIncomeLossBeforeTax1 AOCI Including Portion Attributable to Noncontrolling Interest, before Tax USD 0 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -59,583 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 476.52M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 43.55M 2012-12-31 2013 Q1 10-Q 2013-05-21 0001554757-13-000346
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 358,906 2007-01-01 2007-12-31 2011 FY 10-K 2012-04-16 0001424884-12-000026
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 8.43M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 735,934 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682054
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 728,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 556,044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AssetManagementFees Asset Management Fees (Deprecated 2013-01-31) USD 3,750 2014-01-01 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap Assets Assets USD 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AssetsCurrent Assets, Current USD 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 910,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap AssetsNoncurrent Assets, Noncurrent USD 17.03M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 5.05M 2018-10-01 2018-10-17 2018 Q3 10-Q 2018-11-13 0001144204-18-059353
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 57,607 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap Cash Cash USD 48.71M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001410578-21-000089
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 423,373 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 9.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -7.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 11.80M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 4.30M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001144204-18-059353
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CashFlowsBetweenTransferorAndTransfereeBeneficialInterest Cash Flows Between Transferor and Transferee, Beneficial Interest USD 7.07M 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -4.04M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001144204-19-025316
us-gaap CashProvidedByUsedInDiscontinuedOperationsOperatingActivities Cash Provided by (Used in) Discontinued Operations, Operating Activities (Deprecated 2009-01-31) USD -16.42M 1999-07-27 2012-12-31 2012 FY 10-K 2013-05-15 0001554757-13-000319
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 18.66M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -6.10M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 17.20M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001410578-23-002307
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD -581 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.5 2018-05-14 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 500,000 2020-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 716,819 2018-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 7.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ClearanceFees Clearance Fees USD 1.56M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 811,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 130.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 16.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 16.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 384,343 2013-09-30 2013 Q3 10-Q 2013-11-19 0001589728-13-000008
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 25,000 2012-03-31 2012 Q1 10-Q 2012-05-21 0001424884-12-000038
us-gaap CommonStockValue Common Stock, Value, Issued USD 16,672 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -30.82M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1.48M 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ConvertibleDebt Convertible Debt USD 4.70M 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 31.00M 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 568,127 2011-09-30 2011 Q3 10-Q 2011-11-21 0001424884-11-000163
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 52,942 2014-12-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 3.16M 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value USD 10.00M 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap CostsAndExpenses Costs and Expenses USD 38.87M 1999-07-27 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 721,045 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) USD 58,334 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -15,156 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap CustodyFees Custody Fees USD 8.92M 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1.63M 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtCurrent Debt, Current USD 77,421 2011-03-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.23 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal Debt Instrument, Convertible, If-converted Value in Excess of Principal USD 3.70M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.43M 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 525,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.1 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 16.84M 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 332,156 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 173,000 2015-01-01 2015-06-30 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount USD 196,204 2014-12-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued USD 0 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 35,968 2011-12-31 2012 FY 10-K 2013-05-15 0001554757-13-000319
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -1.26M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 747 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.26M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.46M 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other USD -58,334 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap DeferredRentCredit Deferred Rent Credit USD 33,000 2019-01-01 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap DeferredRevenue Deferred Revenue USD 200,000 2022-03-31 2022 Q1 10-Q 2022-05-13 0001410578-22-001389
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 974,799 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredSalesInducementsAdditions Deferred Sale Inducement Cost, Capitalization USD 8.26M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001424884-15-000168
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 8,000 2021-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 43.33M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 29,777 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.46M 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 40.90M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 186.80M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 38.60M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 811,961 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 21,000 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 18,072 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 43.33M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 9,415 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Plan Assets (Deprecated 2017-01-31) USD -775 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap Depreciation Depreciation USD 800,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 818,216 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 213,228 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD -582,300 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 29,000 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 29,000 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 31,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 5.10M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain Derivative Instruments Not Designated as Hedging Instruments, Gain USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD 581 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DerivativeLiabilities Derivative Liability USD 677,086 2012-12-31 2013 Q1 10-Q 2013-05-21 0001554757-13-000346
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap DerivativeLiabilityFairValueGrossAsset Derivative Liability, Fair Value, Gross Asset USD 582,300 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 87.29M 2015-03-31 2015 Q1 10-Q 2015-05-15 0001424884-15-000050
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax USD 8.73M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 8.73M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax USD -2.92M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation USD 63,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 7.24M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent USD 2.56M 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 4.32M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap Dividends Dividends USD 4.50M 2016-08-10 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap DueFromRelatedParties Due from Related Parties USD -369,346 2013-12-31 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 1.00M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 2.50M 2022-12-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 97,400 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.43 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001410578-21-000089
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.193 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 130,732 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity USD 700,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 67,897 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 945,000 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 3.16M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap ExtinguishmentOfDebtGainLossIncomeTax Extinguishment of Debt, Gain (Loss), Income Tax USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -9.12M 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 7.69M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001424884-15-000124
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-05 0001144204-17-024823
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.99 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInTradingRevenue Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss) Included in Trading Revenue (Deprecated 2013-01-31) USD -423,191 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 15.45M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -31,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 0 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 16.84M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2020-12-31 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 24.95M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -5.24M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682054
us-gaap FederalHomeLoanBankAdvancesDiscount Federal Home Loan Bank, Advances, Discount USD 0 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap FinancingInterestExpense Financing Interest Expense USD 35,269 2014-01-01 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 492,365 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap FinancingReceivableAllowanceForCreditLossesRecoveries Financing Receivable, Allowance for Credit Losses, Recoveries (Deprecated 2012-01-31) USD -1.37M 1999-07-27 2013-12-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap FinancingReceivableAllowanceForCreditLossesRecovery Financing Receivable, Allowance for Credit Loss, Recovery USD -200,000 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -9.31M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -25,995 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -26.84M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap GainLossOnSaleOfDebtInvestments Gain (Loss) on Sale of Debt Investments USD -13.17M 1999-07-27 2013-09-30 2013 Q3 10-Q 2013-11-19 0001589728-13-000008
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 290,500 1999-07-27 2013-12-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -5,399 1999-07-27 2013-12-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap GainLossOnSalesOfLoansNet Gain (Loss) on Sales of Loans, Net USD -243,475 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -24,697 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 5,399 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap GovernmentAssistanceNonoperatingIncome GovernmentAssistanceNonoperatingIncome USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap GovernmentContractReceivable Government Contract Receivable USD 1,077 2012-12-31 2013 Q1 10-Q 2013-05-21 0001554757-13-000346
us-gaap GrantsReceivable Grants Receivable USD 9.50M 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -10.73M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -12.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -10.73M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -1.19 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -1.19 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 5.81M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0.66 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0.66 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 42,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -15,156 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -1,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 90,207 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 11,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 4.51M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -15,156 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 221,940 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 64,897 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -681,550 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-111502
us-gaap IncreaseDecreaseInContractReceivablesNet Increase (Decrease) in Contract Receivables, Net USD -1,055 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 24,013 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 974,799 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -31,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD 1.00M 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-15 0001410578-24-000865
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 244,158 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) USD -338,297 2014-01-01 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap IncreaseDecreaseInFinanceReceivables Increase (Decrease) in Finance Receivables USD -83,247 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap IncreaseDecreaseInNotesPayableRelatedParties Increase (Decrease) in Notes Payable, Related Parties USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap IncreaseDecreaseInNotesPayableRelatedPartiesCurrent Increase (Decrease) in Notes Payable, Related Parties, Current USD 919,845 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -127,803 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 22,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 76,367 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 357,576 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001410578-25-001342
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -504,409 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001144204-17-040922
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 70,315 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682054
us-gaap InsuredEventGainLoss Insured Event, Gain (Loss) USD 11,250 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap InterestAndOtherIncome Interest and Other Income USD 33,344 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap InterestIncomeSecuritiesCorporateDebtOperating Interest Income, Securities, Corporate Debt, Operating USD 492,296 2014-01-01 2014-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap InterestReceivable Interest Receivable USD 559 2020-12-31 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 27,410 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 337,231 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap LeaseCost Lease, Cost USD 393,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 300,000 2020-06-30 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap LegalFees Legal Fees USD 210,255 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-15 0001424884-15-000050
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 9.22M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.59M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.25M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.16M 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.16M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.18M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.29M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 751,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.74M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap Liabilities Liabilities USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 21.25M 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682054
us-gaap LiabilitiesFairValueDisclosureRecurring Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 894,643 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 6.82M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 91,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap LifeSettlementContractsFairValueMethodGainLoss Life Settlement Contracts, Fair Value Method, Gain (Loss) USD 26.84M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap LoansAndLeasesReceivableCommercial Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) USD -23,000 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap LoansPayable Loans Payable USD 42,200 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap LoansPayableCurrent Loans Payable, Current USD 18,000 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 2.40M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001410578-21-000089
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 362,000 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 1.60M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-10 0001104659-21-102826
us-gaap LossOnContracts Loss on Contracts USD 103,950 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap ManagementFeeExpense Management Fee Expense USD 15,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ManagementFeePayable Management Fee Payable USD 67,500 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ManagementFeesRevenue Management Fees Revenue (Deprecated 2018-01-31) USD -3.46M 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap MinorityInterestPreferredStockAmount Noncontrolling Interest, Preferred Stock Amount (Deprecated 2016-01-31) USD 500,000 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD -2.90M 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-15 0001410578-24-000865
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.86M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001410578-24-000297
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 18.66M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -7.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -10.91M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -6.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -10.98M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap NetInvestmentIncome Net Investment Income USD -41.49M 1999-07-27 2012-12-31 2012 FY 10-K 2013-05-15 0001554757-13-000319
us-gaap NoninterestExpense Noninterest Expense USD 41.49M 1999-07-27 2012-12-31 2012 FY 10-K 2013-05-15 0001554757-13-000319
us-gaap NotesPayable Notes Payable USD 30,000 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap NotesPayableCurrent Notes Payable, Current USD 5,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001144204-18-059353
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 23,000 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 82,500 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 2.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OperatingExpenses Operating Expenses USD 9.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -9.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OperatingLeaseCost Operating Lease, Cost USD 258,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.49M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 665,082 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.82M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeasePayments Operating Lease, Payments USD 232,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.33M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 153,518 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 832,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 294,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 3,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 71,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 229,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 234,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1,000 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 1.20M 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 175,600 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.055 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap OptionIndexedToIssuersEquityShares Option Indexed to Issuer's Equity, Shares shares 439,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001144204-18-043366
us-gaap OptionIndexedToIssuersEquityStrikePrice1 Option Indexed to Issuer's Equity, Strike Price USD/shares 1.03 2014-07-01 2014-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 234,962 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OtherAssetsCurrent Other Assets, Current USD 7,203 2026-06-30 2026 Q2 10-Q 2026-08-14 0001104659-26-097262
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 367 2011-01-01 2011-12-31 2011 FY 10-K 2012-04-16 0001424884-12-000026
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -34.07M 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -58,334 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -32.41M 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap OtherExpenses Other Expenses USD 2.40M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap OtherExtraordinaryGainLoss Other Extraordinary Gain (Loss) (Deprecated 2019-01-31) USD -3.90M 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap OtherIncome Other Income USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap OtherLiabilities Other Liabilities USD 0 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001875
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 244,158 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OtherNoncashExpense Other Noncash Expense USD 6.40M 1999-07-27 2013-09-30 2013 Q3 10-Q 2013-11-19 0001589728-13-000008
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 8,677 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 2.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PartnersCapitalAccountExchangesAndConversions Partners' Capital Account, Exchanges and Conversions USD 24.90M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap PartnersCapitalAccountPrivatePlacementOfUnits Partners' Capital Account, Private Placement of Units USD 2.33M 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap PaymentForManagementFee Payment for Management Fee USD -4.50M 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 316,508 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap PaymentsForConstructionInProcess Payments for Construction in Process USD 6.79M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-09 0001104659-21-033855
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 71,710 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 41,500 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 804,070 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 1.30M 2020-04-01 2020-06-30 2020 Q3 10-Q 2020-11-09 0001104659-20-123055
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 99,821 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001104659-20-059515
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 15,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap PostconfirmationDeferredFinancingCosts Postconfirmation, Debt Issuance Costs USD 13,439 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 22,504 2012-09-30 2012 Q3 10-Q 2012-11-19 0001554757-12-000408
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 642,905 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 483,717 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 68,803 2015-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD 7.43M 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 387,500 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 418,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 9.86M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.14M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 600,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 52,942 1999-07-27 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 140,000 1999-07-27 2013-12-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q/A 2016-04-14 0001193125-16-541449
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 1.79M 1999-07-27 2012-12-31 2012 FY 10-K 2013-05-15 0001554757-13-000319
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 32,200 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 62,159 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 550,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap ProfessionalFees Professional Fees USD 614,264 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -6.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 17.79M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 11.70M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap PublicUtilitiesAllowanceForFundsUsedDuringConstructionAdditions Public Utilities, Allowance for Funds Used During Construction, Additions USD -7.29M 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap RecapitalizationCosts Recapitalization Costs USD 1.90M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap ReceivablesFromCustomers Receivables from Customers USD 288,000 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 5,200 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 215,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 5,200 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD -15,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001193125-16-541539
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 20,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap RepaymentsOfDebt Repayments of Debt USD 15,000 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 25,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 13.10M 2021-08-01 2021-08-31 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 99,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 116.04M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap RestrictedCash Restricted Cash USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0001410578-25-001342
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 387,973 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -466.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 751,691 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001104659-26-062763
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 200,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap Revenues Revenues USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 180,000 2011-02-01 2011-02-28 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap SalariesWagesAndOfficersCompensation Salary and Wage, Excluding Cost of Good and Service Sold USD 200,000 2016-08-01 2016-08-31 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 8.34 2018-10-17 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap SecuritiesReceivedAsCollateralAmountRepledgedAndSold Securities Received as Collateral, Amount Repledged and Sold USD 120,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap ServiceManagementCosts Service Management Costs (Deprecated 2018-01-31) USD 58,500 2014-01-01 2014-03-31 2014 Q1 10-Q/A 2014-05-21 0001424884-14-000063
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 1.35M 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap SeveranceCosts1 Severance Costs USD 900,000 2023-04-01 2023-06-30 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 556,044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 300,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 66,000 2015-01-01 2015-06-30 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 500,000 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.17 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.01M 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.68 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares -833 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 103,000 2016-07-01 2016-07-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0.18 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.41 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.069 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.552 2015-03-06 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 500,000 2018-10-01 2018-10-19 2018 FY 10-K 2019-03-15 0001144204-19-014350
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 8.00M 2018-10-16 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 7,619 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 461,202 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 26.57 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 203,900 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 27,660 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 150,000 2015-03-06 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 278 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 18 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 563,368 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.76M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.77 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 33,333 2015-05-31 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 18 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001410578-24-001978
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.43 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 2.39 2015-01-01 2015-09-30 2015 Q3 10-Q/A 2016-04-14 0001193125-16-541488
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 35.66 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 0.18 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost USD 14,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap SharePrice Share Price USD/shares 3.92 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap SharesIssued Shares, Issued shares 100,000 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 2.5 2018-05-14 2018 Q3 10-Q 2018-11-13 0001144204-18-059353
us-gaap ShortTermBorrowings Short-term Debt USD 67,942 2012-12-31 2013 Q1 10-Q 2013-05-21 0001554757-13-000346
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.15 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 26,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap StockDividendsShares Stock Dividends, Shares shares 150,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 248,561 2015-01-01 2015-06-30 2015 Q2 10-Q/A 2016-04-14 0001193125-16-541467
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationForfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited USD 62,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 40,238 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 10.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 12 2016-09-01 2016-09-16 2016 Q3 10-Q 2016-11-04 0001144204-16-131724
us-gaap StockIssued1 Stock Issued USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001144204-17-014490
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 10,191 2016-05-01 2016-05-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.23M 2021-03-16 2022 FY 10-K 2023-03-22 0001410578-23-000324
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 1.40M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 25,602 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap StockIssuedDuringPeriodSharesTreasuryStockReissued Stock Issued During Period, Shares, Treasury Stock Reissued shares 61,167 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-19 0001424884-14-000121
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 116.04M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 70,315 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-23 0001144204-18-016734
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 1.92M 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 9.86M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 2.42M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 556,044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 62,159 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 71,710 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032463
us-gaap SubscriptionRevenue Subscription and Circulation Revenue (Deprecated 2018-01-31) USD -140,000 1999-07-27 2014-06-30 2014 Q2 10-Q 2014-08-18 0001424884-14-000092
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 220,290 2013-12-31 2014 FY 10-K 2015-04-15 0001424884-15-000039
us-gaap TenantImprovements Tenant Improvements USD 1.00M 2021-12-31 2021 FY 10-K 2022-03-17 0001410578-22-000418
us-gaap TreasuryStockShares Treasury Stock, Shares shares 586,858 2011-06-01 2012 Q2 10-Q/A 2012-09-12 0001424884-12-000052
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-031274
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap USGovernmentAgenciesSecuritiesAtCarryingValue US Government Agencies Securities, at Carrying Value USD 8.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -1.29M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001410578-25-000549
us-gaap VariableLeaseCost Variable Lease, Cost USD 109,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001410578-23-001217
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 69.82M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-10 0001104659-21-102826
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001104659-26-128441

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →